The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Konar re. Hasiba, I get it. But in 12.23, this, 'severe illness and hospitalisation are less common', was comforting and let's hope later research confirms it.
Certainly though, a storm for a T-cell ! A long way to go IMO. ATB
Don't worry - he'll be back tomorrow to tell you the exact opposite and that you've misinterpreted what he said yesterday.
Maybe it would have been more believable if he’d have said storm in a T cup…
@TorquayFan - clearly none of that can be true, because Hasiba told us yesterday that it was a "storm in a tea cup" ;-)
Pfizer CEO today says the world will Need booster shots for years and years to come.
Grim thought.
Scancell to the rescue?
Just been watching 'Sky' and thoughts from RSA are transmissibilty is very high, previous infection doesn't protect, maybe the vaccines do protect a little, BUT, severe illness and hospitalisation are less common. I leave it to others to get that more precise. ATB
What Scancell will be doing is comparing T Cell and antibody levels against data published for approved vaccines. She had already done this on the animal experiments and stated that the data was better than the equivalent animal data for approved vaccines.
Lindy has previously stated that the N protein is particularly immunogenic so targeting it has the potential to have an effect against not just against covid19 but any coronavirus.
The other great advantage of an immunobody vaccine is that it is easy to add new targets.
We should be looking at expanding the SA trial IMO. It would be great to multiply the 40 candidates many times. Yes we are in the right place at the right time but risk being overlooked by big pharma and ministers as 40 people just isn’t enough to drive this in the AZ way. Saw this at Synairgen with its covid therapeutic. Scancell need to be driving this and not let events dictate…
In saying all of that. Outstanding data won’t do us any harm should we be left on the shelf. Longer term, there will be other variants.
Or, if COVIDITY were to be proven nearly 100% it could not be ignored.
My understanding is that the phase 1 trial of covidity will not prove the effectiveness against Covid19. The aims are to prove it is safe and to collect data about the levels of appropriate antibodies and T Cells.
Lindy should actually be in the room considering the subject matter. If not at least Jonathan Ball
A lot of 'ifs', however the current timescale for covidity assumes no forced acceleration with outside help (think how the original vaccines got pushed along their timescales) So if the early covidity data is as good as we would hope, and the extension of trial to the UK is still on, it could be perfect timing for Scancell in these difficult times.
Since we know the government are aware of scancell as they have provided some funding, one would assume that scancell Will be a topic off discussion at this meeting.
The main paragraph reads
“On Thursday, the Prime Minister will convene a summit of scientists and leaders of the pharmaceutical industry, as part of efforts to tackle emerging variants and create “variant-proof” vaccines within 100 days. “
is it possible to cut and paste as its behind a paywall
Very interesting
https://www.telegraph.co.uk/news/2021/12/01/two-rounds-boosters-come-government-orders-variant-proof-covid/
does not surprise me !!!
Just bought another 24k
Showing as a sell
Interestingly the USA patient had both vaccines but not the booster. Symptons seem mild.
Highlights to me the stupidity of anti vaccers. Lets hope for a good day
And the Sky article (both links seem to make a mockery of some views expressed on here yesterday)
https://news.sky.com/story/amp/covid-19-emerging-picture-from-south-africa-suggests-omicron-variant-could-be-real-cause-for-concern-12484064
The Guardian 01:04 - "Omicron becomes dominant variant in South Africa - The heavily mutated Omicron variant has propelled a sharp rise in Covid cases in South Africa as health experts describe the degree of increase as “worrying”.
The variant now accounts for 74% of all the virus genomes sequenced in the nation last month after it was first found in a sample taken on 8 November in Gauteng, South Africa’s most populous province. Covid cases have risen from a weekly average of around 300 new cases per day to 1,000 last week and most recently to 3,500. A total of 8,561 new cases were reported on Wednesday alone - double the number of new cases recorded the day before, according to data from the National Institute for Communicable Diseases (NICD).
Dr Michelle Groome, head of the NICD, said the increase was “exponential” adding that the “rapidly increasing number of new daily cases” was “fuelled by the variant” known as Omicron, Agence France-Presse reports. South Africa’s National Institute for Communicable Diseases (NICD) said early epidemiological data suggested Omicron was able to evade some immunity, but existing vaccines should still protect against severe disease and death.
World Health Organization (WHO) epidemiologist Maria van Kerkhove told a briefing that data on how contagious Omicron was should be available “within days.” "
https://www.theguardian.com/world/live/2021/dec/02/coronavirus-news-live-south-africa-sees-exponential-increase-in-covid-cases-dominated-by-omicron-variant
DeAar,
Thanks.
RR,
Here’s the explanation.
https://www.google.co.uk/amp/s/mobile.reuters.com/article/amp/idUSL1N2SI07K
Why is this "latest" variant called omicron? Omicron is the 15th letter of the Greek alphabet so what happened to the 10 letters in between, have I missed them?
Southern Africa is not a hotbed of variants — it's just very good at sequencing and spotting them